Literature DB >> 26349515

Antimicrobial Activity of Extracts of the Oyster Culinary Medicinal Mushroom Pleurotus ostreatus (Higher Basidiomycetes) and Identification of a New Antimicrobial Compound.

Ahmed M Younis1, Fang-Sheng Wu2, Hussien H El Shikh3.   

Abstract

Pleurotus ostreatus is an edible mushroom that also has high medicinal values. In this study, P. ostreatus was tested for its ability to inhibit the growth of fungi and bacteria. The freeze-dried fruiting body, broth from submerged culture, and mycelial biomass of P. ostreatus were extracted using alcohols and water as solvents. The extracts were then tested for their antimicrobial activity against the growth of fungi and bacteria. It was observed that the water extract from fruiting bodies had the strongest effect in inhibiting the growth of most fungi. The most sensitive test microfungi to the inhibition were Candida albicans, Cryptococcus humicola, and Trichosporon cutaneum, and the most sensitive test bacteria were Staphylococcus aureus followed by Escherichia coli. Water extracts from culture broth or mycelial biomass were moderately inhibitive to the growth of fungi and bacteria. The alcohol-based solvents from all samples had much less antimicrobial activity against most test microorganisms. An antimicrobial compound was purified from the water extracts of fruiting bodies with Sephadex G 100 column chromatography and characterized by infrared absorption spectrum (IR), nuclear magnetic resonance (NMR), and mass spectroscopic analysis. We have identified this compound to be 3-(2-aminopheny1thio)-3-hydroxypropanoic acid. This purified compound had a minimum inhibitory concentration of 30 µg/mL and 20 µg/mL against the growth of fungi and bacteria, respectively.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26349515     DOI: 10.1615/intjmedmushrooms.v17.i6.80

Source DB:  PubMed          Journal:  Int J Med Mushrooms        ISSN: 1940-4344            Impact factor:   1.921


  7 in total

Review 1.  Historical and current perspectives on therapeutic potential of higher basidiomycetes: an overview.

Authors:  Ruby Varghese; Yogesh Bharat Dalvi; Prasad Y Lamrood; Bharat P Shinde; C K K Nair
Journal:  3 Biotech       Date:  2019-09-17       Impact factor: 2.406

2.  Assessment of the Antibacterial Potential of Biosynthesized Silver Nanoparticles Combined with Vancomycin Against Methicillin-Resistant Staphylococcus aureus-Induced Infection in Rats.

Authors:  Mohammed Awad; Mohamed Yosri; Marwa M Abdel-Aziz; Ahmed M Younis; Nagwa M Sidkey
Journal:  Biol Trace Elem Res       Date:  2021-01-02       Impact factor: 3.738

3.  Antimicrobial Activities and Time-Kill Kinetics of Extracts of Selected Ghanaian Mushrooms.

Authors:  Theresa Appiah; Yaw Duah Boakye; Christian Agyare
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-29       Impact factor: 2.629

4.  Investigation of Antioxidant and Antimicrobial Activities of Different Extracts of Auricularia and Termitomyces Species of Mushrooms.

Authors:  Gebreselema Gebreyohannes; Andrew Nyerere; Christine Bii; Desta B Sbhatu
Journal:  ScientificWorldJournal       Date:  2019-07-24

5.  GC-MS Analysis of Potentially Volatile Compounds of Pleurotus ostreatus Polar Extract: In vitro Antimicrobial, Cytotoxic, Immunomodulatory, and Antioxidant Activities.

Authors:  Doaa Hamad; Heba El-Sayed; Wafaa Ahmed; Hana Sonbol; Mohammed Abdel Halim Ramadan
Journal:  Front Microbiol       Date:  2022-02-18       Impact factor: 5.640

Review 6.  Fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics.

Authors:  Akshay Shankar; Krishna Kant Sharma
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-12       Impact factor: 5.560

Review 7.  Mycopharmaceuticals and Nutraceuticals: Promising Agents to Improve Human Well-Being and Life Quality.

Authors:  Jameel R Al-Obaidi; Nuzul Noorahya Jambari; E I Ahmad-Kamil
Journal:  J Fungi (Basel)       Date:  2021-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.